Products 5241-22-5

CAS 5241-22-5 is the registry number for Methost-8-enol. Offered by: TRC, Biosynth. Available pack sizes: 50mg, 5mg, 10mg, 25mg.

Methost-8-enol
TRC, Biosynth
  • size: 50mg, 5mg, 10mg, 25mg
  • Variants: 5
View product
Structural formula: {0} (CAS {1})

4alpha-methyl-5alpha-cholest-8-en-3beta-ol is a 3beta-sterol that is 5alpha-cholest-8-en-3beta-ol carrying an additional methyl substituent at position 4alpha. It has a role as a human metabolite. It is a 3beta-sterol and a cholestanoid.

Source: ChEBI

Identity
Molecular formulaC28H48O
Molecular weight400.7 g/mol
IUPAC name(3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChIKeySCEZIHJVTBQOLS-YIJYGBTNSA-N
SMILESC[C@H]1[C@@H]2CCC3=C([C@]2(CC[C@@H]1O)C)CC[C@]4([C@H]3CC[C@@H]4[C@H](C)CCCC(C)C)C

Computed by PubChem (NCBI)

Synonyms: Methost-8-enol, Cholest-8-en-3-ol, 4-methyl-, (3beta,4alpha,5alpha)-, (3beta,4alpha,5alpha)-4-methylcholest-8-en-3-ol, 4alpha-methyl-5alpha-cholest-8-en-3beta-ol, 4alpha-Methylcholesta-8-en-3beta-ol, 4alpha-methyl-cholesta-8-enol, 4-methylcholesta-8-en-3-ol, 4-Methylcholest-8-en-3-ol (3beta,4alpha,5alpha)-, 4a-Methylcholesta-8-en-3b-ol, 4a-methyl-24(25)-dihydrozymosterol
Isomers (same molecular formula)
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4R,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,5S,9R,10S,13R,14R,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3S,4S,8S,9S,10R,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(3R,4S,5S,9R,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O
(5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C28H48O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-methyl-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C28H48O